According to OKYO Pharma, OK-101 is the first drug candidate to enroll patients specifically diagnosed with neuropathic ...

The study, conducted in 2022, highlights significant variations in glaucoma prevalence across different demographic groups, ...

The company will seek a strategic partner to continue development of APX3330, an oral small-molecule inhibitor of Ref-1 for ...

Acknowledging complex dynamics is an important part of traveling abroad as a doctor, according to University of Colorado ...

According to the company, its data replicate and expand upon the potential of ER-100 to improve retinal ganglion cell ...

According to a study presented at the American Academy of Ophthalmology’s annual meeting in Chicago, investigational ...

In a paper presented at the American Academy of Ophthalmology annual meeting in Chicago, Jonathan Tan, a third year medical student at the Icahn School of Medicine at Mount Sinai detailed the study on ...

Abdelrahman Elhusseiny, MD, MSc, sat down with David Hutton of Ophthalmology Times to discuss his presentation on the risk of ...

George O. Waring, IV, MD provides insights from an on-demand poster as part of the annual American Academy of Ophthalmology ...

Nathan Radcliffe, MD, shared insights from his presentation at the annual meeting of the American Academy of Ophthalmology ...

In an interview with Ophthalmology Times, Quan Dong Nugyen, MD, MSc, discusses ongoing research into Tinlarebant, an ...

Christina Y Weng, MD, MBA sat down to discuss the Retina Ophthalmic Technology Assessment Symposium and her journal on ...